KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Retained Earnings: 2009-2025

Historic Retained Earnings for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to -$14.2 billion.

  • Teva Pharmaceutical Industries' Retained Earnings rose 4.77% to -$14.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.2 billion, marking a year-over-year increase of 4.77%. This contributed to the annual value of -$15.2 billion for FY2024, which is 12.11% down from last year.
  • Teva Pharmaceutical Industries' Retained Earnings amounted to -$14.2 billion in Q3 2025, which was up 2.95% from -$14.7 billion recorded in Q2 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Retained Earnings ranged from a high of -$2.4 billion in Q2 2021 and a low of -$15.2 billion during Q4 2024.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Retained Earnings value was -$14.2 billion (recorded in 2025), while the average stood at -$13.3 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first soared by 76.39% in 2021, then plummeted by 406.22% in 2024.
  • Over the past 5 years, Teva Pharmaceutical Industries' Retained Earnings (Quarterly) stood at -$2.7 billion in 2021, then dropped by 5.78% to -$2.8 billion in 2022, then slumped by 376.89% to -$13.5 billion in 2023, then dropped by 12.11% to -$15.2 billion in 2024, then climbed by 4.77% to -$14.2 billion in 2025.
  • Its Retained Earnings was -$14.2 billion in Q3 2025, compared to -$14.7 billion in Q2 2025 and -$15.0 billion in Q1 2025.